Abstract
Radionuclide myocardial perfusion imaging (MPI) plays a vital role in the evaluation and management of patients with coronary artery disease. However, because of a steep growth in MPI in the mid 2000s, concerns about inappropriate use of MPI and imaging-related radiation exposure increased. In response, the professional societies developed appropriate-use criteria for MPI. Simultaneously, novel technology, image-reconstruction software for traditional scanners, and dedicated cardiac scanners emerged and facilitated the performance of MPI with low-dose and ultra-low-dose radiotracers. This paper provides a practical approach to performing low-radiation-dose MPI using traditional and novel technologies.
Original language | English (US) |
---|---|
Pages (from-to) | 592-599 |
Number of pages | 8 |
Journal | Journal of Nuclear Medicine |
Volume | 56 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2015 |
Externally published | Yes |
Keywords
- Low dose
- Myocardial perfusion imaging
- PET
- Quality assurance
- Radiation dose
- SPECT
ASJC Scopus subject areas
- Medicine(all)